These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34671005)

  • 41. Next-Generation Sequencing-Based Genomic Profiling of Children with Acute Myeloid Leukemia.
    Krizsán S; Péterffy B; Egyed B; Nagy T; Sebestyén E; Hegyi LL; Jakab Z; Erdélyi DJ; Müller J; Péter G; Csanádi K; Kállay K; Kriván G; Barna G; Bedics G; Haltrich I; Ottóffy G; Csernus K; Vojcek Á; Tiszlavicz LG; Gábor KM; Kelemen Á; Hauser P; Gaál Z; Szegedi I; Ujfalusi A; Kajtár B; Kiss C; Matolcsy A; Tímár B; Kovács G; Alpár D; Bödör C
    J Mol Diagn; 2023 Aug; 25(8):555-568. PubMed ID: 37088137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution.
    Miller CA; White BS; Dees ND; Griffith M; Welch JS; Griffith OL; Vij R; Tomasson MH; Graubert TA; Walter MJ; Ellis MJ; Schierding W; DiPersio JF; Ley TJ; Mardis ER; Wilson RK; Ding L
    PLoS Comput Biol; 2014 Aug; 10(8):e1003665. PubMed ID: 25102416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subclonal patterns in follow-up of acute myeloid leukemia combining whole exome sequencing and ultrasensitive IBSAFE digital droplet analysis.
    Pettersson L; Chen Y; George AM; Rigo R; Lazarevic V; Juliusson G; Saal LH; Ehinger M
    Leuk Lymphoma; 2020 Sep; 61(9):2168-2179. PubMed ID: 32425124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Difference in gene mutation profile in patients with refractory/relapsed versus newly diagnosed acute myeloid leukemia based on targeted next-generation sequencing.
    Wang M; Wang R; Wang H; Chen C; Qin J; Gao X; Yu L
    Leuk Lymphoma; 2021 Oct; 62(10):2416-2427. PubMed ID: 33913388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clonal dynamics in a case of acute monoblastic leukemia that later developed myeloproliferative neoplasm.
    Sato S; Itonaga H; Taguchi M; Sawayama Y; Imanishi D; Tsushima H; Hata T; Moriuchi Y; Mishima H; Kinoshita A; Yoshiura KI; Miyazaki Y
    Int J Hematol; 2018 Aug; 108(2):213-217. PubMed ID: 29417354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Application and clinical study of clonal heterogeneity analysis in acute myeloid leukemia].
    Lyu XD; Guo Z; Li YW; Hu JY; Fan RH; Song YP
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):483-489. PubMed ID: 32654462
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia.
    Tan Y; Liu Z; Wang W; Zhu G; Guo J; Chen X; Zheng C; Xu Z; Chang J; Ren F; Wang H
    Leuk Res; 2018 Jun; 69():89-93. PubMed ID: 29705537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of recurring tumor-specific somatic mutations in acute myeloid leukemia by transcriptome sequencing.
    Greif PA; Eck SH; Konstandin NP; Benet-Pagès A; Ksienzyk B; Dufour A; Vetter AT; Popp HD; Lorenz-Depiereux B; Meitinger T; Bohlander SK; Strom TM
    Leukemia; 2011 May; 25(5):821-7. PubMed ID: 21339757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.
    Jan M; Snyder TM; Corces-Zimmerman MR; Vyas P; Weissman IL; Quake SR; Majeti R
    Sci Transl Med; 2012 Aug; 4(149):149ra118. PubMed ID: 22932223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disease evolution and outcomes in familial AML with germline CEBPA mutations.
    Tawana K; Wang J; Renneville A; Bödör C; Hills R; Loveday C; Savic A; Van Delft FW; Treleaven J; Georgiades P; Uglow E; Asou N; Uike N; Debeljak M; Jazbec J; Ancliff P; Gale R; Thomas X; Mialou V; Döhner K; Bullinger L; Mueller B; Pabst T; Stelljes M; Schlegelberger B; Wozniak E; Iqbal S; Okosun J; Araf S; Frank AK; Lauridsen FB; Porse B; Nerlov C; Owen C; Dokal I; Gribben J; Smith M; Preudhomme C; Chelala C; Cavenagh J; Fitzgibbon J
    Blood; 2015 Sep; 126(10):1214-23. PubMed ID: 26162409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?
    Yilmaz M; Wang F; Loghavi S; Bueso-Ramos C; Gumbs C; Little L; Song X; Zhang J; Kadia T; Borthakur G; Jabbour E; Pemmaraju N; Short N; Garcia-Manero G; Estrov Z; Kantarjian H; Futreal A; Takahashi K; Ravandi F
    Blood Cancer J; 2019 Jan; 9(2):7. PubMed ID: 30651532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutational profiling of acute myeloid leukemia with normal cytogenetics in Brazilian patients: the value of next-generation sequencing for genomic classification.
    de Noronha TR; Mitne-Neto M; Chauffaille ML
    J Investig Med; 2017 Dec; 65(8):1155-1158. PubMed ID: 28923882
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics and prognostic significance of genetic mutations in acute myeloid leukemia based on a targeted next-generation sequencing technique.
    Wang RQ; Chen CJ; Jing Y; Qin JY; Li Y; Chen GF; Zhou W; Li YH; Wang J; Li DW; Zhao HM; Wang BH; Wang LL; Wang H; Wang MZ; Gao XN; Yu L
    Cancer Med; 2020 Nov; 9(22):8457-8467. PubMed ID: 32970934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
    Jongen-Lavrencic M; Grob T; Hanekamp D; Kavelaars FG; Al Hinai A; Zeilemaker A; Erpelinck-Verschueren CAJ; Gradowska PL; Meijer R; Cloos J; Biemond BJ; Graux C; van Marwijk Kooy M; Manz MG; Pabst T; Passweg JR; Havelange V; Ossenkoppele GJ; Sanders MA; Schuurhuis GJ; Löwenberg B; Valk PJM
    N Engl J Med; 2018 Mar; 378(13):1189-1199. PubMed ID: 29601269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a Next-generation Sequencing-based Gene Panel Test to Detect Measurable Residual Disease in Acute Myeloid Leukemia.
    Kim JJ; Jang JE; Lee HA; Park MR; Kook HW; Lee ST; Choi JR; Min YH; Shin S; Cheong JW
    Ann Lab Med; 2023 Jul; 43(4):328-336. PubMed ID: 36843401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation.
    Luskin MR; Carroll M; Lieberman D; Morrissette JJD; Zhao J; Crisalli L; Roth DB; Luger SM; Porter DL; Reshef R
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):1961-1967. PubMed ID: 27478011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation.
    Cocciardi S; Dolnik A; Kapp-Schwoerer S; Rücker FG; Lux S; Blätte TJ; Skambraks S; Krönke J; Heidel FH; Schnöder TM; Corbacioglu A; Gaidzik VI; Paschka P; Teleanu V; Göhring G; Thol F; Heuser M; Ganser A; Weber D; Sträng E; Kestler HA; Döhner H; Bullinger L; Döhner K
    Nat Commun; 2019 May; 10(1):2031. PubMed ID: 31048683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Real-Time Characterization of Clonal Fate Decisions in Complex Leukemia Samples by Fluorescent Genetic Barcoding.
    Maetzig T; Lieske A; Dörpmund N; Rothe M; Kleppa MJ; Dziadek V; Hassan JJ; Dahlke J; Borchert D; Schambach A
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clonal Evolution and Changes in Two AML Patients Detected with A Novel Single-Cell DNA Sequencing Platform.
    Xu L; Durruthy-Durruthy R; Eastburn DJ; Pellegrino M; Shah O; Meyer E; Zehnder J
    Sci Rep; 2019 Jul; 9(1):11119. PubMed ID: 31366893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.